ASX - By Stock
|
IMM |
Re:
orphan drug definitions...
|
|
Hodgie28
|
47 |
17K |
19 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
47
|
17K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
|
|
Hodgie28
|
146 |
79K |
13 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
146
|
79K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
|
|
Hodgie28
|
146 |
79K |
29 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
146
|
79K
|
29
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep achieves Fast Track designation for Efti from US FDA
|
|
Hodgie28
|
68 |
44K |
13 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
68
|
44K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep achieves Fast Track designation for Efti from US FDA
|
|
Hodgie28
|
68 |
44K |
20 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
68
|
44K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Letter from Leslie
|
|
Hodgie28
|
37 |
17K |
12 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
37
|
17K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces European Patent Grant for LAG525
|
|
Hodgie28
|
10 |
6.7K |
14 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
10
|
6.7K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces European Patent Grant for LAG525
|
|
Hodgie28
|
10 |
6.7K |
9 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
10
|
6.7K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
36 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
127
|
63K
|
36
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
15 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
127
|
63K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
11 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
127
|
63K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
6 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
127
|
63K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
9 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
127
|
63K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
12 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
127
|
63K
|
12
|
|
ASX - By Stock
|
PTX |
Re:
Cancer-free after 12 years: Why you’re hearing the C-word more often
|
|
Hodgie28
|
68 |
34K |
18 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
68
|
34K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
34 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
127
|
63K
|
34
|
|
ASX - By Stock
|
IMM |
Re:
90 cents is the price target
|
|
Hodgie28
|
127 |
63K |
13 |
28/03/21 |
28/03/21 |
ASX - By Stock
|
127
|
63K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Why is IMMP up?
|
|
Hodgie28
|
67 |
35K |
21 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
67
|
35K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Hodgie28
|
127 |
64K |
14 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
127
|
64K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Hodgie28
|
127 |
64K |
23 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
127
|
64K
|
23
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Imugene - Charts & Price Action (New thread)
|
|
Hodgie28
|
1.7K |
918K |
10 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
1.7K
|
918K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Hodgie28
|
127 |
64K |
10 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
127
|
64K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Phase II study for eftilagimod alpha in COVID-19 advances
|
|
Hodgie28
|
127 |
64K |
28 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
127
|
64K
|
28
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep collaborates with MSD for phase 2b head & neck trial
|
|
Hodgie28
|
40 |
23K |
11 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
40
|
23K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
ATTENTION!! Only the Phase 2 Interim Results to be presented at ACS
|
|
Hodgie28
|
48 |
22K |
10 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
48
|
22K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
Cancer-free after 12 years: Why you’re hearing the C-word more often
|
|
Hodgie28
|
68 |
34K |
20 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
68
|
34K
|
20
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Imugene - Charts & Price Action (New thread)
|
|
Hodgie28
|
1.7K |
918K |
18 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
1.7K
|
918K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep secures second US patent grant for eftilagimod alpha
|
|
Hodgie28
|
29 |
18K |
11 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
29
|
18K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present HER-Vaxx Phase 2 Data at AACR21 Meeting
|
|
Hodgie28
|
146 |
79K |
48 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
146
|
79K
|
48
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
Hodgie28
|
35 |
19K |
15 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
35
|
19K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
Hodgie28
|
35 |
19K |
12 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
35
|
19K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
Hodgie28
|
35 |
19K |
11 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
35
|
19K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part B of TACTI-002 collaboration trial
|
|
Hodgie28
|
35 |
19K |
13 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
35
|
19K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Merck US$1.85b takeover of clinical autoimmune biotech company
|
|
Hodgie28
|
42 |
19K |
25 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
42
|
19K
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Merck US$1.85b takeover of clinical autoimmune biotech company
|
|
Hodgie28
|
42 |
19K |
23 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
42
|
19K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Merck US$1.85b takeover of clinical autoimmune biotech company
|
|
Hodgie28
|
42 |
19K |
7 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
42
|
19K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
Hodgie28
|
5 |
3.4K |
11 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
5
|
3.4K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
Hodgie28
|
33 |
17K |
18 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
33
|
17K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Half Yearly Report and Accounts
|
|
Hodgie28
|
33 |
17K |
16 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
33
|
17K
|
16
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Appendix 4D and Half Year Financial Report
|
|
Hodgie28
|
5 |
3.4K |
11 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
5
|
3.4K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
PTX100, Professor H.Miles Prince, Car-T and OmniCAR
|
|
Hodgie28
|
145 |
66K |
14 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
145
|
66K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Althium Capital, Sold their position
|
|
Hodgie28
|
21 |
12K |
11 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
21
|
12K
|
11
|
|
Humour
|
|
Re:
AFTER THE VIRUS .
|
|
Hodgie28
|
1 |
866 |
1 |
13/02/21 |
13/02/21 |
Humour
|
1
|
866
|
1
|
|
ASX - By Stock
|
IMM |
Re:
How is our CEO being compensated.
|
|
Hodgie28
|
19 |
7.6K |
7 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
19
|
7.6K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
86 |
38K |
16 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
86
|
38K
|
16
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX announces 3 next-gen CAR-T programs with OmniCAR
|
|
Hodgie28
|
220 |
82K |
9 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
220
|
82K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX announces 3 next-gen CAR-T programs with OmniCAR
|
|
Hodgie28
|
220 |
82K |
22 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
220
|
82K
|
22
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Corporate Presentation
|
|
Hodgie28
|
86 |
38K |
4 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
86
|
38K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: FDA Grants ACW Rare Paediatric Disease Designation in FXS
|
|
Hodgie28
|
46 |
15K |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
46
|
15K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: FDA Grants ACW Rare Paediatric Disease Designation in FXS
|
|
Hodgie28
|
46 |
15K |
2 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
46
|
15K
|
2
|
|